In compliance with Regulation 30 & 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, it is hereby informed that, the Board of Directors in its meeting held on May 13, 2026, have inter-alia, considered and approved the following matters:a. To consider and approve the resolution for extension of time for utilization of net issue proceeds and completion of project as stated in the prospectus.b. To consider and approve the resolution for utilization of funds under General Corporate Purpose (GCP) for working capital requirements as well.c. Any other item- Discussion regarding faults in the Company's hardware and software systems which resulted in unexpected shutdown of certain systems for a temporary period and were subsequently restored/recovered.
Modern Diagnostic & Research Centre Limited Press Release May 13 2026
Filed with BSE · · 1 page · English
Release
Modern Diagnostic & Research Centre Limited on 6ix
Earlier from Modern Diagnostic & Research Centre
- Modern Diagnostic & Research Centre Limited Press Release May 02 2026
- Modern Diagnostic & Research Centre Limited Press Release Apr 16 2026
- Modern Diagnostic & Research Centre Limited Press Release Mar 30 2026
- Modern Diagnostic & Research Centre Limited Press Release Mar 09 2026
- Modern Diagnostic & Research Centre Limited Press Release Feb 28 2026
Later from Modern Diagnostic & Research Centre
- Modern Diagnostic & Research Centre Limited Press Release May 21 2026
- Modern Diagnostic & Research Centre Limited Press Release Aug 26 2026
- Modern Diagnostic & Research Centre Limited Press Release Sep 03 2026
- Modern Diagnostic & Research Centre Limited Press Release Sep 05 2026
- Modern Diagnostic & Research Centre Limited Press Release Sep 06 2026
Follow Modern Diagnostic & Research Centre into a list and get an email when it puts out news.
Follow Modern Diagnostic & Research Centre